Fletcher Aaron G.L.'s Form 4 filing
Cognition Therapeutics Inc (CGTX) · filed Nov 16, 2022
- Accession no.
- 0001104659-22-119341
- Filed
- Nov 16, 2022, 7:00 AM ET
- Trade date
- Nov 15, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $1.80M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Fletcher Aaron G.L.CIK 0001789490 | Director |
| BIOS Memory SPV I, LPCIK 0001643749 | 10% Owner |
| BIOS Fund I, LPCIK 0001697316 | 10% Owner |
| BIOS Fund I QP, LPCIK 0001700297 | 10% Owner |
| BIOS Fund II, LPCIK 0001714576 | 10% Owner |
| BIOS Fund II QP, LPCIK 0001716869 | 10% Owner |
| Bios Equity Partners II, LPCIK 0001813313 | 10% Owner |
| Bios Equity Partners, LPCIK 0001813314 | 10% Owner |
| BIOS Advisors GP, LLCCIK 0001813844 | 10% Owner |
| BIOS Capital Management, LPCIK 0001813845 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 15, 2022 | Common Stock | PPurchaseAcquired | +184,270 | $1.20 | +$221,124 | 316,038 | Indirect | Duplicate filing |
| Nov 15, 2022 | Common Stock | PPurchaseAcquired | +1,141,030 | $1.20 | +$1,369,236 | 1,955,677 | Indirect | Duplicate filing |
| Nov 15, 2022 | Common Stock | PPurchaseAcquired | +174,700 | $1.20 | +$209,640 | 299,608 | Indirect | Duplicate filing |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.